ClinicalTrials.Veeva

Menu

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes (ELITE)

University of Kansas logo

University of Kansas

Status

Not yet enrolling

Conditions

Kidney Stone
Nephrolithiasis

Treatments

Device: INTRARENAL PRESSURE MONITORING VISIBLE

Study type

Interventional

Funder types

Other

Identifiers

NCT06576661
STUDY00160851

Details and patient eligibility

About

The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

Full description

Despite advances in surgical techniques and technology, preventable adverse events still occur in the operating room, with half of them attributed to poor non-technical skills of surgical teams. Therefore, it is essential to observe and measure surgeons' intraoperative non-technical skills and provide structured feedback to improve patient safety. The new LithoVue Elite™ disposable ureteroscope has the potential to impact surgeons' behavior during ureteroscopy, as it enables the measurement of real-time intrarenal pressures. The study is designed to evaluate urologists' behavior during ureteroscopic stone treatment with and without intra-renal pressure monitoring.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males or females over 18 years of age
  • Undergoing flexible ureteroscopy to address urinary stones located in the proximal ureter or kidney
  • Total stone burden over 2 cm

Exclusion criteria

  1. Undergoing bilateral stone treatment during the same procedure
  2. Patients with known genitourinary anatomical abnormalities
  3. Uncorrected coagulopathy
  4. Patients with urinary diversions
  5. Chronic external urinary catheters
  6. Women who are pregnant
  7. Immunosuppressed patients

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

URS WITH INTRARENAL PRESSURE MONITORING VISIBLE
Active Comparator group
Description:
In Arm 1, participants will undergo URS with real-time IRP monitoring visible to surgeons using the LithoVue Elite™. Participants will be scheduled to undergo URS per standard of care. All follow-up visits will be scheduled per standard of care.
Treatment:
Device: INTRARENAL PRESSURE MONITORING VISIBLE
URS WITHOUT INTRARENAL PRESSURE MONITORING VISIBLE
No Intervention group
Description:
In Arm 2, participants will undergo URS LithoVue Elite™ without the real-time IRP monitoring information visible to the surgeon. Participants will be scheduled to undergo URS per standard of care. All follow-up visits will be scheduled per standard of care.

Trial contacts and locations

1

Loading...

Central trial contact

Jane Ledesma

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems